Article
GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model.
Translational research : the journal of laboratory and clinical medicine - 1 Oct 2023
Chen Chunxia, Tang Xihe, Lan Zhaohui, Chen Wan, Su Hua, Li Weidong, Li Yaoxuan, Zhou Xing, Gao Hong, Feng Xinwei, Guo Ying, Yao Meicun, Deng Wenbin
Abstract excerpt
The CLU rs11136000C mutation (CLUC) is the third most common risk factor for Alzheimer's disease (AD). However, the mechanism by which CLUC leads to abnormal GABAergic signaling in AD is unclear. To address this question, this study establishes the first chimeric mouse model of CLUC AD. Examination of grafted CLUC medial ganglionic eminence progenitors (CLUC hiMGEs) revealed increased GAD65/67 and a high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
